Unknown

Dataset Information

0

CHAGASIC MENINGOENCEPHALITIS IN AN HIV INFECTED PATIENT WITH MODERATE IMMUNOSUPPRESSION: PROLONGED SURVIVAL AND CHALLENGES IN THE HAART ERA.


ABSTRACT: The reactivation of Chagas disease in HIV infected patients presents high mortality and morbidity. We present the case of a female patient with confirmed Chagasic meningoencephalitis as AIDS-defining illness. Interestingly, her TCD4+ lymphocyte cell count was 318 cells/mm3. After two months of induction therapy, one year of maintenance with benznidazol, and early introduction of highly active antiretroviral therapy (HAART), the patient had good clinical, parasitological and radiological evolution. We used a qualitative polymerase chain reaction for the monitoring of T. cruzi parasitemia during and after the treatment. We emphasize the potential value of molecular techniques along with clinical and radiological parameters in the follow-up of patients with Chagas disease and HIV infection. Early introduction of HAART, prolonged induction and maintenance of antiparasitic therapy, and its discontinuation are feasible, in the current management of reactivation of Chagas disease.

SUBMITTER: Buccheri R 

PROVIDER: S-EPMC4727143 | biostudies-other | 2015 Dec

REPOSITORIES: biostudies-other

altmetric image

Publications

CHAGASIC MENINGOENCEPHALITIS IN AN HIV INFECTED PATIENT WITH MODERATE IMMUNOSUPPRESSION: PROLONGED SURVIVAL AND CHALLENGES IN THE HAART ERA.

Buccheri Renata R   Kassab Maria José MJ   Freitas Vera Lucia Teixeira de VL   Silva Sheila Cristina Vicente da SC   Bezerra Rita C RC   Khoury Zarifa Z   Shikanai-Yasuda Maria Aparecida MA   Vidal José E JE  

Revista do Instituto de Medicina Tropical de Sao Paulo 20151201 6


The reactivation of Chagas disease in HIV infected patients presents high mortality and morbidity. We present the case of a female patient with confirmed Chagasic meningoencephalitis as AIDS-defining illness. Interestingly, her TCD4+ lymphocyte cell count was 318 cells/mm3. After two months of induction therapy, one year of maintenance with benznidazol, and early introduction of highly active antiretroviral therapy (HAART), the patient had good clinical, parasitological and radiological evolutio  ...[more]

Similar Datasets

| S-EPMC6613183 | biostudies-literature
| S-EPMC5340610 | biostudies-literature
| S-EPMC4260326 | biostudies-literature
| S-EPMC4374841 | biostudies-literature
| S-EPMC4524598 | biostudies-literature
| S-EPMC3530027 | biostudies-literature
| S-EPMC9301576 | biostudies-literature
| S-EPMC4122584 | biostudies-literature
| S-EPMC4018741 | biostudies-literature
| S-EPMC7772547 | biostudies-literature